Company Reinforces Commitment to Rare Disease Community through its Promise of Support® Program
Maple Grove, MN – December 1, 2025 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of KYMBEE™ (deflazacort) Tablets, indicated for the treatment ... Read More
